In a commentary for APM's Marketplace, Dr. Stefan Kertesz questions the current process of approving new drugs, especially when researchers who set health care guidelines also have financial interests in pharmaceutical companies. He cites the timing of the National Cholesterol Education Panel's announcement on recommended cholesterol levels and the drug Vytorin's release to illustrate the need for reform.
is a publication by Science in Society, a Northwestern University research center for science outreach and public engagement.
In this 10-week seminar – co-taught by Science in Society and Medill School of Journalism, Media, and Integrated Marketing Communications – Northwestern graduate students hone their writing skills through authentic writing assignments for general readers. The course is supported by TGS and open to all STEM+ PhD candidates....
Add new comment